Li Liang

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

Yuankai Shi, Li Zhang, Xiaoqing Liu et al. · The Lancet Oncology · 2013 · 420 citations

Double-blind Phase 3, Medicine, Metronomic Therapy +9

Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region

Shenghui Wu, Shih‐Ming Huang, Jinjun Ding et al. · Oncogene · 2010 · 389 citations

Transcriptional Regulation, Chromatin Structure, Untranslated Region +11

Enhanced Recovery After Surgery (ERAS) Program Attenuates Stress and Accelerates Recovery in Patients After Radical Resection for Colorectal Cancer: A Prospective Randomized Controlled Trial

Li Ren, Dexiang Zhu, Ye Wei et al. · World Journal of Surgery · 2011 · 234 citations

The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma

Lei Chen, He‐Xin Yan, Wen Yang et al. · Journal of Hepatology · 2008 · 224 citations

Tumor Biology, Microrna Expression Pattern, Hepatology +11

Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial

Zhijie Wang, Ying Cheng, Tongtong An et al. · The Lancet Respiratory Medicine · 2018 · 214 citations

Oncology, Tumour Dna, Medicine +10